Stephens Inc. AR Has $3.15 Million Stake in Genpact Limited $G

Stephens Inc. AR grew its stake in Genpact Limited (NYSE:GFree Report) by 10.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 71,587 shares of the business services provider’s stock after purchasing an additional 6,761 shares during the period. Stephens Inc. AR’s holdings in Genpact were worth $3,151,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Cornerstone Planning Group LLC acquired a new position in Genpact in the 1st quarter valued at approximately $27,000. Richardson Financial Services Inc. acquired a new position in Genpact in the 1st quarter valued at approximately $35,000. Steph & Co. acquired a new position in Genpact in the 2nd quarter valued at approximately $37,000. SVB Wealth LLC acquired a new position in Genpact in the 1st quarter valued at approximately $41,000. Finally, Kestra Investment Management LLC acquired a new position in Genpact in the 1st quarter valued at approximately $56,000. Institutional investors and hedge funds own 96.03% of the company’s stock.

Analyst Upgrades and Downgrades

G has been the topic of a number of analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Genpact in a research note on Wednesday, October 8th. Needham & Company LLC raised their price target on shares of Genpact from $50.00 to $53.00 and gave the stock a “buy” rating in a research note on Friday, August 8th. Mizuho increased their target price on Genpact from $48.00 to $51.00 and gave the stock a “neutral” rating in a report on Tuesday, July 1st. Citigroup assumed coverage on Genpact in a report on Wednesday. They issued a “neutral” rating and a $43.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on Genpact in a report on Thursday, July 17th. They issued a “hold” rating and a $47.00 target price for the company. Three equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $51.13.

View Our Latest Research Report on Genpact

Insiders Place Their Bets

In related news, SVP Piyush Mehta sold 76,902 shares of the firm’s stock in a transaction on Friday, September 12th. The stock was sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the completion of the sale, the senior vice president directly owned 134,880 shares of the company’s stock, valued at $5,743,190.40. This trade represents a 36.31% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Balkrishan Kalra sold 55,000 shares of the firm’s stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $43.36, for a total value of $2,384,800.00. Following the sale, the chief executive officer directly owned 295,246 shares of the company’s stock, valued at $12,801,866.56. This represents a 15.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 3.07% of the company’s stock.

Genpact Trading Down 1.4%

G stock opened at $39.75 on Thursday. The business has a fifty day moving average price of $42.45 and a 200 day moving average price of $44.04. Genpact Limited has a fifty-two week low of $37.82 and a fifty-two week high of $56.76. The stock has a market capitalization of $6.93 billion, a price-to-earnings ratio of 13.20, a P/E/G ratio of 1.38 and a beta of 0.89. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 1.53.

Genpact (NYSE:GGet Free Report) last released its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating analysts’ consensus estimates of $0.85 by $0.03. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The firm had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.23 billion. During the same period last year, the firm posted $0.79 EPS. The business’s revenue was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Tuesday, December 9th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, December 9th. Genpact’s dividend payout ratio (DPR) is currently 22.59%.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Read More

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.